15/05/2017

We are pleased to announce that as part of our rebranding strategy, our brand name has now changed from Anapharm Europe to Anapharm Bioanalytics.

READ MORE

28/04/2016

Anapharm Europe is proud to announce that it has successfully undergone its first US FDA inspection at its Barcelona based bioanalytical lab.

READ MORE

03/03/2016

Anapharm Europe is proud to announce that it has recently renewed its ANVISA (Brazil) certificate.

READ MORE

16/04/2015

Anapharm Europe has renewed its certification to offer the advantages of the French research tax credit (crédit d’impôt recherche) for period 2015 – 2019.

READ MORE

19/01/2015

Anapharm Biotech, the peptide and protein chemistry division of Anapharm Europe, has completed method development of biomarkers Anti-IIa, Anti-Xa and TPFI in human plasma by chromogenic assays and ELISA, respectively.

READ MORE

15/11/2014

Anapharm Europe has improved the limit of quantification for analysis of Formoterol achieving a LLOQ of 0.2 pg/mL in Human Plasma.

READ MORE

02/09/2014

Anapharm Europe has renewed once more its Certificate for Good Laboratory Practice Principles (GLP).

READ MORE

04/04/2014

Anapharm Europe has renewed once more its Certificate for ANVISA (Brasil).

READ MORE

21/01/2014

Anapharm Europe has updated the calibration range of its LC/MS/MS analytical method for Tiotropium achieving a limit of quantification of 0.2 pg/mL

READ MORE